Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_3
2
40%
Ph not_applicable
1
20%
Ph phase_4
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
2(40.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Other(1)

Detailed Status

Not yet recruiting2
Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 32 (40.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

not_yet_recruiting240%
completed240%
unknown120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingphase_3

Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver Transplantation

NCT07759453
not_yet_recruitingphase_4

The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)

NCT07556107
completedphase_3

Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock

NCT02473263
unknownphase_2

Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections

NCT05060419
completednot_applicable

Comparison of 9 Doses vs 3 Doses of Post Operative Antibiotics in Live Liver Donors

NCT03765645

Clinical Trials (5)

Showing 5 of 5 trials
NCT07759453Phase 3

Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver Transplantation

Not Yet Recruiting
NCT07556107Phase 4

The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS)

Not Yet Recruiting
NCT02473263Phase 3

Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock

Completed
NCT05060419Phase 2

Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections

Unknown
NCT03765645Not Applicable

Comparison of 9 Doses vs 3 Doses of Post Operative Antibiotics in Live Liver Donors

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5